Our previous finding that Sirt2-deficient mice developed pancreatic cancer with an oncogenic mutant Kras background11 also supports our notion since tumor development is closely linked with the increasing age partly due to the impaired immune system integrity33. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.